Entries by CAPTIS

Amgen's Repatha lowers heart attack, stroke risk in phase 3 study

PBR Staff Writer Published 20 March 2017 A phase 3 study has demonstrated that Amgen’s cholesterol drug Repatha reduces low-density lipoprotein cholesterol (LDL-C) levels and risk of cardiovascular events. The trial demonstrated that Repatha has maximum reduced low-density lipoprotein cholesterol (LDL-C) levels, helping to decrease the risk of major cardiovascular events such as heart attacks, […]

UK’s NICE recommends Boston Scientific’s CRT-Ds with longer battery life

MDBR Staff Writer Published 20 March 2017 The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Boston Scientific’s Enduralife-powered cardiac resynchronisation therapy-defibrillator (CRT-D) devices to treat heart failure patients. Enduralife-based CRT-D will enable to treat patients with a type of heart failure that reduce the efficiency of left chamber […]

Texas Medicaid payment reform initiative curbs elective early deliveries

Even though the health risks to babies born before they reach full term at 39 weeks have long been recognized, nearly 1 in 10 babies in the United States is born prematurely. Texas decided to try to change that. In 2011, the Texas Medicaid program was the first in the country to take steps to curb elective early […]

MiMedx Announces The Addition Of To Its Board Of Directors

MARIETTA, Ga., March 19, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and therapies for multiple sectors of healthcare, announced today its Board of Directors has appointed Luis A. Aguilar, former Commissioner of the […]

NuVasive Release: New Evidence-Based Recommendation Released From NICE (U.K.) For Lateral Interbody Fusion

SAN DIEGO, March 20, 2017 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced updated guidance from the National Industry for Clinical Excellence (NICE) in the U.K. for lateral interbody fusion in the lumbar spine. NICE stated the evidence on efficacy for […]

Abbott Release: Late-Breaking Data Shows The CardioMEMS HF System Is Effective In Reducing Heart Failure Hospitalizations And Cost Of Care

WASHINGTON, March 19, 2017 /PRNewswire/ — New late-breaking featured clinical research presented today adds strong clinical support for Abbott’s CardioMEMS HF System as an effective real-world approach to reduce heart failure hospitalizations and combat the rising cost of heart failure. The CardioMEMS HF System is the first and only U.S. Food and Drug Administration-approved monitor […]

Is This New Device The Future Of The Workplace?

We become so limited by this idea of technology replacing workers when the better idea is to power-up their senses and extend what they’re capable of doing. So says Brian Mullins, founder and CEO of the augmented-reality device maker DAQRI. Those are powerful words, especially in a world where championing and empowering common workers can take […]

CytoSorbents Release: CytoSorb Treatment Of HLH – The Parallel To Cytokine Release Syndrome In Cancer Immunotherapy

MONMOUTH JUNCTION, N.J., March 20, 2017 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, highlights recent cases using CytoSorb to successfully treat HLH (hemophagocytic lymphohistiocytosis) and their relevance to cytokine release syndrome (CRS) in […]

Mazor Robotics And Medtronic Combine Efforts On The Commercialization Of Mazor X: An Innovative Guidance System For Spine Surgery

ORLANDO, Fla., March 17, 2017 /PRNewswire/ — Mazor Robotics Ltd. is a global leader in the development and distribution of innovative surgical guidance systems for spine and brain surgery. Mazor Robotics Inc., the US subsidiary of Mazor Robotics LTD is recognized as one of largest players in the robotics and simulation industry in the State […]

Karmanos Cancer Institute Now Offering New Technology To Detect Prostate Cancer

DETROIT, March 20, 2017 /PRNewswire-USNewswire/ — The Barbara Ann Karmanos Cancer Institute is using a sophisticated new way to more effectively diagnose and treat prostate cancer. Urology specialists at Karmanos have begun using the UroNav Fusion Biopsy System, which fuses three dimensional MRI (magnetic resonance imaging) images of the prostate with live ultrasound images to precisely […]